Ontario Brain Institute Funds Five Neurotech Entrepreneurs Through Its Annual NERVE Program
Summary
The Ontario Brain Institute is investing $500,000 across five Canadian neurotechnology entrepreneurs through its Neurotech Entrepreneurship to Validate Emerging Innovations (NERVE) program, described as Canada's largest single award for early-stage neurotechnology. Each entrepreneur receives $100,000 in non-dilutive funding along with a 12-month program of mentorship, training, and commercialization support. This year's cohort spans concussion detection, surgical safety, neurosurgery, neurodegenerative disease treatment, and pain management. NERVE is now a recurring annual program; OBI reports having invested more than $5 million in neurotechnology entrepreneurship to date, supporting over 100 entrepreneurs and helping move 25 brain-health products to market.
Why it matters
Non-dilutive, mentorship-backed funding for very early-stage neurotech founders fills a gap that traditional venture capital often skips -- OBI's own reported $168M in follow-on investment from past NERVE cohorts suggests this kind of pre-seed institutional support has a real track record of pulling companies into fundable shape.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial